Work Here?
Overview
pulseData provides AI-driven analytics tools for kidney care, focusing on CKD and ESRD. Its platform helps healthcare providers identify high-risk patients, predict renal failure events, and monitor care workflows. The product is offered via subscriptions to hospitals, clinics, and health systems, enabling value-based care by reducing unnecessary costs and targeting interventions. The system distinguishes itself by concentrating specifically on kidney disease and aligning with programs like CMS Kidney Care Choices to improve patient outcomes while lowering overall care costs. The company's goal is to deliver actionable insights that enable providers to deliver targeted, cost-effective care for patients with CKD and ESRD.
About pulseData
Industries
Data & Analytics
Enterprise Software
AI & Machine Learning
Healthcare
Company Size
11-50
Company Stage
Series A
Total Funding
$19.7M
Headquarters
New York City, New York
Founded
2015
Simplify's Take
What believers are saying
- Clinical validation and explainability fit enterprise procurement requirements.
- Undiagnosed CKD identification supports gap closure and value-based care performance.
- Workflow automation expands beyond analytics into care management operations.
What critics are saying
- NavDeep kidney analytics already compete for early CKD identification and routing.
- Model parity across AI-augmented CKD vendors erodes pricing power.
- Outcomes not independently proven can slow adoption and renewals.
What makes pulseData unique
- Patented AI predicts CKD progression and adverse events at point of care.
- Ingests EHR, claims, and pharmacy data into workflow-integrated risk scores.
- Targets payers, providers, ACOs, and value-based care organizations with actionable insights.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$19.7M
Meets
Industry Average
Funded Over
2 Rounds
Industry standards
Growth & Insights and Company News
6 month growth
↑ 11%1 year growth
↑ 11%2 year growth
↑ 11%Vytalize Health partnered with pulseData to efficiently and precisely identify the members of its population who are most at risk.
pulseData, a New York City-based healthcare data science company focused on predictive algorithms for Chronic Kidney Disease and other chronic diseases, raised $16.5m in Series A funding. The round was led by Bain Capital Private Equity and Two Bear Capital, with participation from Alumni Ventures Group and existing investors. The company intends to use the funds to […]
pulseData is working at the forefront of community health to develop techniques to risk stratify individuals at the earliest stages of renal disease.
There are no jobs for pulseData right now.
Find jobs on Simplify and start your career today
About pulseData
Industries
Data & Analytics
Enterprise Software
AI & Machine Learning
Healthcare
Company Size
11-50
Company Stage
Series A
Total Funding
$19.7M
Headquarters
New York City, New York
Founded
2015
There are no jobs for pulseData right now.
Find jobs on Simplify and start your career today